Patients undergoing chronic haemodialysis are known to have a high inc
idence of premature atherosclerosis for reasons which have not been fu
lly elucidated. The susceptibility of low density lipoprotein (LDL) to
oxidation by copper ions in vitro is widely used as a measure of its
atherogenicity in vivo. We measured the susceptibility of LDL to oxida
tion using copper ions in haemodialysis patients and found, surprising
ly, a markedly increased resistance to oxidation. The experiment was t
herefore repeated using an alternative free radical generator, AAPH [2
,2'-azobis-(2-amidinopropane hydrochloride)], to promote LDL oxidation
; using AAPH, the susceptibility to oxidation was similar in the dialy
sis group compared to controls. Abnormal LDL composition in the dialys
is patients was also demonstrated. We suggest that, in such situations
, susceptibility of LDL to oxidation in vitro may be highly dependent
on the biochemical method employed and therefore may not accurately re
flect atherogenic risk.